Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients

被引:30
|
作者
Tangedal, Solveig [1 ,2 ]
Nielsen, Rune [1 ,2 ]
Aanerud, Marianne [2 ]
Persson, Louise J. [2 ]
Wiker, Harald G. [1 ,4 ]
Bakke, Per S. [1 ]
Hiemstra, Pieter S. [3 ]
Eagan, Tomas M. [1 ,2 ]
机构
[1] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway
[2] Haukeland Hosp, Dept Thorac Med, Bergen, Norway
[3] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands
[4] Haukeland Hosp, Dept Microbiol, Bergen, Norway
来源
PLOS ONE | 2019年 / 14卷 / 09期
关键词
LUNG MICROBIOME; BACTERIAL; DYNAMICS;
D O I
10.1371/journal.pone.0222449
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Exacerbations of chronic obstructive pulmonary disease (COPD) are debilitating events and spur disease progression. Infectious causes are frequent; however, it is unknown to what extent exacerbations are caused by larger shifts in the airways' microbiota. The aim of the current study was to analyse the changes in microbial composition between stable state and during exacerbations, and the corresponding immune response. Methods The study sample included 36 COPD patients examined at stable state and exacerbation from the Bergen COPD Cohort and Exacerbations studies, and one patient who delivered sputum on 13 different occasions during the three-year study period. A physician examined the patients at all time points, and sputum induction was performed by stringent protocol. Only induced sputum samples were used in the current study, not spontaneously expectorated sputum. Sputum inflammatory markers (IL-6, IL-8, IL-18, IP-10, MIG, TNF-alpha) and antimicrobial peptides (AMPs, i.e. LL-37/hCAP-18, SLPI) were measured in supernatants, whereas target gene sequencing (16S rRNA) was performed on corresponding cell pellets. The microbiome bioinformatics platform QIIME2 (TM) and the statistics environment R were applied for bioinformatics analyses. Results Levels of IP-10, MIG, TNF-alpha and AMPs were significantly different between the two disease states. Of 36 sample pairs, 24 had significant differences in the 12 most abundant genera between disease states. The diversity was significantly different in several individuals, but not when data was analysed on a group level. The one patient case study showed longitudinal dynamics in microbiota unrelated to disease state. Conclusion Changes in the sputum microbiota with changing COPD disease states are common, and are accompanied by changes in inflammatory markers. However, the changes are highly individual and heterogeneous events.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
    Rosenwasser, Yehudis
    Berger, Irene
    Loewy, Zvi G.
    [J]. PATHOGENS, 2022, 11 (12):
  • [32] Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
    Butorac-Petanjek, B.
    Parnham, M. J.
    Popovic-Grle, S.
    [J]. JOURNAL OF CHEMOTHERAPY, 2010, 22 (05) : 291 - 297
  • [33] Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations
    Mao, Xiaoyan
    Li, Yao
    Shi, Pengfei
    Zhu, Ziwei
    Sun, Juan
    Xue, Yu
    Wan, Zongren
    Yang, Dan
    Ma, Ting
    Wang, Jipeng
    Zhu, Rong
    [J]. MICROBIAL PATHOGENESIS, 2023, 184
  • [34] Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada
    Noorduyn, Stephen
    Soliman, Mena
    Qian, Christina
    Johnston, Karissa
    Penz, Erika
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [35] Human Beta Defensin 2 Levels Are Reduced In The Sputum Of Chronic Obstructive Pulmonary Disease (COPD) Patients And Are Associated With The Occurrence Of Exacerbations
    McCrae, C.
    Zhou, Y.
    Qian, J.
    Zheng, J.
    Tang, R.
    Zheng, J.
    Nilsson, A.
    Zhang, M.
    Bruijnzeel, P.
    Saltzman, J.
    Vaarala, O.
    Chen, R.
    Zhong, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
    Haaland, Ingvild
    Tangedal, Solveig
    Nielsen, Rune
    Aanerud, Marianne
    Bakke, Per S.
    Eagan, Tomas M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [37] Changing Pattern of Sputum Cell Counts During Successive Exacerbations of Chronic Obstructive Pulmonary Disease
    Wang, Hongyu
    Dasgupta, Angira
    Lee, Ker-Ai
    Cook, Richard J.
    Nair, Parameswaran
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (06) : 628 - 635
  • [38] Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study
    Husebo, Gunnar R.
    Bakke, Per S.
    Aanerud, Marianne
    Hardie, Jon A.
    Ueland, Thor
    Gronseth, Rune
    Persson, Louise J. P.
    Aukrust, Pal
    Eagan, Tomas M.
    [J]. PLOS ONE, 2014, 9 (10):
  • [39] Evaluation of cardiac arrest during severe chronic obstructive pulmonary disease (COPD) exacerbations
    Sardi, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 177A - 177A
  • [40] Evaluation of cardiac arrest during severe exacerbations of chronic obstructive pulmonary disease (COPD)
    Sardi, G
    Sardi, A
    Murali, G
    Quercia, I
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A66 - A66